INT204722

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.30
First Reported 2007
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 1.69
Pain Relevance 0.11

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (ALCAM) cell adhesion (ALCAM)
Anatomy Link Frequency
leukocyte 2
bone marrow 1
ALCAM (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 51 78.40 Quite High
cytokine 46 70.48 Quite High
imagery 5 35.76 Quite Low
Inflammatory stimuli 10 5.00 Very Low Very Low Very Low
dexamethasone 6 5.00 Very Low Very Low Very Low
COX2 4 5.00 Very Low Very Low Very Low
Inflammatory response 4 5.00 Very Low Very Low Very Low
corticosteroid 3 5.00 Very Low Very Low Very Low
fibrosis 3 5.00 Very Low Very Low Very Low
Arthritis 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Adhesions 2 100.00 Very High Very High Very High
Pancreatic Cancer 2 99.84 Very High Very High Very High
Cancer 6 97.68 Very High Very High Very High
Classical Swine Fever 2 95.84 Very High Very High Very High
Lyme Disease 4 89.80 High High
Obesity 8 89.20 High High
INFLAMMATION 65 78.40 Quite High
Disease 162 59.24 Quite High
Pulmonary Disease 186 46.24 Quite Low
Nicotine Addiction 14 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Vaisocherova et al devised an SPR assay for detection of the candidate pancreatic cancer marker activated cell leukocyte adhesion molecule (ALCAM) that can be used to distinguish between ALCAM levels in cancer and control sera [192].
Positive_regulation (activated) of leukocyte adhesion molecule in leukocyte associated with cancer, pancreatic cancer and adhesions
1) Confidence 0.30 Published 2009 Journal Respir Res Section Body Doc Link PMC2678087 Disease Relevance 0.68 Pain Relevance 0
Vaisocherova et al devised an SPR assay for detection of the candidate pancreatic cancer marker activated cell leukocyte adhesion molecule (ALCAM) that can be used to distinguish between ALCAM levels in cancer and control sera [192].
Positive_regulation (activated) of ALCAM in leukocyte associated with cancer, pancreatic cancer and adhesions
2) Confidence 0.30 Published 2009 Journal Respir Res Section Body Doc Link PMC2678087 Disease Relevance 0.68 Pain Relevance 0
Both MSCs were positive for CD73, CD90, CD105, CD166 and negative for CD34, CD45, CD19 and HLA-DR (Figure 2, Figure S1).
Positive_regulation (positive) of CD166
3) Confidence 0.13 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2814860 Disease Relevance 0.33 Pain Relevance 0.11
At flow cytometry analysis AM-hMSCs showed an immunophenotypical profile, i.e., positive for CD105, CD73, CD29, CD44, CD166 and negative for CD14, CD34, CD45, consistent with that reported for bone marrow-derived MSCs.
Positive_regulation (positive) of CD166 in bone marrow
4) Confidence 0.09 Published 2007 Journal BMC Dev Biol Section Abstract Doc Link PMC1810523 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox